Jiangsu Nhwa Pharmaceutical News and Activities

Jiangsu Nhwa Pharmaceutical is one of the...

• CSI 500;
• TOB Iconic 10,000.

Jiangsu Nhwa Pharmaceutical is a company listed under the stock ticker 002262 (CN).

View the org chart displaying its 10 main executives

Most searched biographies at Jiangsu Nhwa Pharmaceutical

• Jiaquan Sun, Director and Chief Executive Officer
• Yulan Li, Independent Director
• Pengsheng Sun, Chairman of the Board

Create your alert
to follow the executive moves at Jiangsu Nhwa Pharmaceutical.

Jiangsu Nhwa Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Jiangsu Nhwa Pharmaceutical

Social media about Jiangsu Nhwa Pharmaceutical

• Jiangsu Nhwa Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Jiangsu Nhwa Pharmaceutical on LinkedIn, X (Twitter) & YouTube